Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Options, Profile, Reports, Research, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 22-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 40)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
22-May-13 New Constructs, LLC N/A VRX: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
22-May-13 Stock Traders Daily Thomas H Kee Jr. Trading Report for (VRX). A detailed report, including free correlated market analysis, and updates. 5 $57.50 View Abstract
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
22-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Valeant Pharmaceuticals International Inc 43 $494.50 View Abstract
21-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - VALEANT PHARMACEUTICALS INTERNATIONAL INC (VRX-N) 12 $25 View Abstract
21-May-13 Stock Traders Daily Thomas H Kee Jr. The Investment Rate - a measure of investment demand. 43 $494.50 View Abstract
20-May-13 Alpha Street Research Hunter Orr VRX - Valeant Pharmaceuticals International Inc - Rated a Hold - Company Analysis and ASR Ranking Report 9 $24 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala VALEANT PHARMACEUTICALS INTL (VRX) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 S&P Capital IQ – STARS Reports N/A Valeant Pharmaceuticals Intl 10 $115 View Abstract
Next 20

Independent Reports (Showing 1 to 10 of 40)

Release
Date Contributor Author Title Pages Price More Info
22-May-13 New Constructs, LLC N/A VRX: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
22-May-13 Stock Traders Daily Thomas H Kee Jr. Trading Report for (VRX). A detailed report, including free correlated market analysis, and updates. 5 $57.50 View Abstract
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
22-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Valeant Pharmaceuticals International Inc 43 $494.50 View Abstract
21-May-13 Thomson Reuters Stock Report StockReports + Research Department Thomson Reuters Stock Report - VALEANT PHARMACEUTICALS INTERNATIONAL INC (VRX-N) 12 $25 View Abstract
21-May-13 Stock Traders Daily Thomas H Kee Jr. The Investment Rate - a measure of investment demand. 43 $494.50 View Abstract
20-May-13 Alpha Street Research Hunter Orr VRX - Valeant Pharmaceuticals International Inc - Rated a Hold - Company Analysis and ASR Ranking Report 9 $24 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala VALEANT PHARMACEUTICALS INTL (VRX) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 S&P Capital IQ – STARS Reports N/A Valeant Pharmaceuticals Intl 10 $115 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.